Regal Partners Ltd Acquires 30,799 Shares of GE HealthCare Technologies Inc. $GEHC

Regal Partners Ltd increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 264,277 shares of the company’s stock after acquiring an additional 30,799 shares during the quarter. GE HealthCare Technologies makes up 1.4% of Regal Partners Ltd’s investment portfolio, making the stock its 19th largest position. Regal Partners Ltd’s holdings in GE HealthCare Technologies were worth $19,847,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of GEHC. Parallel Advisors LLC lifted its stake in GE HealthCare Technologies by 7.8% in the third quarter. Parallel Advisors LLC now owns 7,802 shares of the company’s stock worth $586,000 after acquiring an additional 562 shares during the period. Natixis Advisors LLC increased its position in GE HealthCare Technologies by 21.6% during the 3rd quarter. Natixis Advisors LLC now owns 568,481 shares of the company’s stock valued at $42,693,000 after buying an additional 101,167 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund boosted its stake in GE HealthCare Technologies by 11.0% in the 3rd quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 62,681 shares of the company’s stock worth $4,707,000 after purchasing an additional 6,193 shares in the last quarter. Korea Investment CORP grew its holdings in shares of GE HealthCare Technologies by 12.2% during the third quarter. Korea Investment CORP now owns 347,167 shares of the company’s stock valued at $26,072,000 after buying an additional 37,666 shares during the last quarter. Finally, Ameriflex Group Inc. increased its holdings in shares of GE HealthCare Technologies by 68.3% in the 3rd quarter. Ameriflex Group Inc. now owns 552 shares of the company’s stock worth $41,000 after purchasing an additional 224 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Evercore raised their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. BTIG Research increased their price objective on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Piper Sandler lifted their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their price target for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Finally, Jefferies Financial Group increased their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Trading Down 3.7%

NASDAQ GEHC opened at $74.27 on Friday. The company has a fifty day simple moving average of $81.81 and a two-hundred day simple moving average of $78.57. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The stock has a market cap of $33.85 billion, a P/E ratio of 16.29, a P/E/G ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the firm earned $1.45 EPS. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.